Application and Effect of "Internet + Nursing" in Hip Fragility Fracture Patients Based on Fracture Liaison Service
Launched by THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE · May 8, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help patients who have suffered hip fragility fractures, which are breaks in the hip bone often caused by falls or minor injuries. These fractures are common among older adults and can lead to serious complications and a significant decline in quality of life. The trial combines a specialized program called the Fracture Liaison Service (FLS) with "Internet + nursing" services. This means that patients will receive ongoing support and care even after leaving the hospital, including online consultations with healthcare teams and home health guidance to help prevent future fractures and aid recovery.
To participate in the trial, individuals must be at least 18 years old, have a diagnosed hip fragility fracture, and be scheduled for surgery. They should also be able to understand the information provided and use smart electronic devices. However, those with certain medical conditions or severe injuries may not be eligible. Participants can expect to receive comprehensive care that continues after their hospital stay, which aims to improve their recovery and reduce the risk of future fractures.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria Age ≥ 18 years
- • Voluntarily signed informed consent
- • Diagnosis of hip fragility fracture (closed type)
- • Scheduled for surgical intervention
- • Adequate communication and comprehension abilities
- • Ability of patient or caregiver to operate smart electronic devices
- • Exclusion Criteria History of psychiatric or neurological disorders (e.g., dementia, schizophrenia)
- • Polytrauma (multiple fractures or major concomitant injuries)
- • Metastatic cancer, metabolic bone disease, or terminal illness
- • Insulin-dependent diabetes mellitus
- • Thyroid disease
- • Inability to participate due to other medical or social factors
About The Fourth Affiliated Hospital Of Zhejiang University School Of Medicine
The Fourth Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary research, the hospital integrates cutting-edge technology and expert clinical practices to support a wide range of medical studies. Its commitment to ethical standards and patient safety ensures the highest quality of research outcomes, making it a trusted partner in the medical community for both national and international clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yiwu, Zhejiang, China
Patients applied
Trial Officials
Cheng li Yan, Bachelor
Principal Investigator
The Fourth Affiliated Hospital of Zhejiang UniversitySchool of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported